Amesite Inc(AMST) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 3 at 4:00 PM ET (Korea 11/4 06:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.63 | Insider Own | 32.94% | Shs Outstand | 6.5M | Perf Week | 1.72% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | 24.05% | Shs Float | 4.4M | Perf Month | -39.22% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 5.99% | Short Float | 0.89% | Perf Quarter | -41% |
| Income | -0.00B | P/S | 10.43 | EPS this Y | - | Inst Trans | 6.38% | Short Ratio | 0.4 | Perf Half Y | -41.46% |
| Sales | 0.00B | P/B | 1.41 | EPS next 5Y | - | ROA | -101.06% | Short Interest | 0.04M | Perf YTD | -69.7% |
| Book/sh | 0.41 | P/C | 1.63 | EPS past 3/5Y | 28.03% 37.84% | ROE | -114.83% | 52W High | -83.85% ($3.55) | Perf Year | -82.9% |
| Cash/sh | 0.35 | P/FCF | - | Sales past 3/5Y | -24.42% -11.57% | ROIC | -116.66% | 52W Low | 10.09% ($0.52) | Perf 3Y | -73.97% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 43.14% | Gross Margin | 23.95% | Volatility(W/M) | 10.93% 7.91% | Perf 5Y | -97.18% |
| Dividend TTM | - | EV/Sales | 4.04 | Sales Y/Y TTM | 230.24% | Oper. Margin | -861.65% | ATR (14) | 0.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.42 | EPS Q/Q | 11.18% | Profit Margin | -848.69% | RSI (14) | 19.8 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.42 | Sales Q/Q | 41.86% | SMA20 | -20.01% ($0.71) | Beta | 1.08 | Target Price | - |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | -36.88% ($0.9) | Rel Volume | 0.19 | Prev Close | $0.57 |
| Employees | 6 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -56.29% ($1.3) | Avg Volume(3M) | 0.10M | Price | $0.57 |
| IPO | 2020/9/25 | Option/Short | No/Yes | Trades | 88 | Volume | 18,224 | Change | 0.69% |
🏥 Amesite (AMST) is a micro-cap technology company that operates an AI-powered learning and healthcare software platform. Originally launched as an edtech business, the company is now pivoting toward healthcare SaaS, centered on NurseMagic, its AI-powered documentation tool for nurses.
Over the past 1 year, on the lower side
84% below its 1-year high.
Traded less than usual. That is 19% of its average volume.
AMST has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $1,043. Peers typically go for $130.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -97.2%. The S&P 500 did +62% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 6.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #211 of 225 in the industry
Based on market cap of $4M.
FAQ
What kind of company is AMST?
AMST belongs to the Technology sector and operates in the Software - Application industry.
What is the market cap of AMST?
The market cap of AMST is approximately $4M, ranking 5,677 within its sector.
What is the 52-week high and low for AMST?
AMST has recorded a 52-week high of $3.55 and a low of $0.52.
